A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin Area
Condition: Dermatitis, Atopic Intervention: Other: Gel Cream Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 7, 2022 Category: Research Source Type: clinical trials
Testing Protocol to Efficiently Induce Itch
Condition: Itch Interventions: Drug: Anti-histamine cream 1 hour; Drug: Local anesthetic cream 1 hour Sponsor: Aalborg University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2022 Category: Research Source Type: clinical trials
Lilly's Lebrikizumab Demonstrated Significant Skin Improvement and Itch Relief When Combined with Topical Corticosteroids in People with Atopic Dermatitis in Third Phase 3 Study
INDIANAPOLIS, Dec. 21, 2021 /PRNewswire/ -- Lebrikizumab, an IL-13 inhibitor, significantly improved disease severity when combined with topical corticosteroids (TCS) in people with moderate-to-severe atopic dermatitis (AD) in Eli Lilly and... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - December 21, 2021 Category: Pharmaceuticals Source Type: clinical trials
Psychogenic and Neurogenic Components in Patients With Psychogenic or Neuropathic Pruritus
Conditions: Pruritus; Psychogenic Skin Disease; Neuropathic Pain; Itch Intervention: Other: Questionnaires Sponsor: University Hospital, Brest Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 27, 2021 Category: Research Source Type: clinical trials
